Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide foam biomarker study in active ulcerative colitis
jRCTs031210326Completed
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of budesonide in autoimmune colitis, sponsored by EA Pharma Co., Ltd. Primary endpoints: Study drug response rate and Change in serum LRG among responders. Started Feb 2022; status: completed.
02
Drugs
budesonide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCTs031210326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210326.